Simplify Logo

Full-Time

Regulatory Associate I/II

Posted on 7/23/2024

Adicet Bio, Inc

Adicet Bio, Inc

51-200 employees

Develops genetically modified T cells for cancer

Hardware
Biotechnology
Healthcare

Compensation Overview

$105k - $146kAnnually

+ Annual Cash Bonus + Long-term Incentives + Employee Stock Purchase Plan

Junior, Mid

San Carlos, CA, USA

Category
Risk & Compliance
Legal & Compliance
Required Skills
Communications
Word/Pages/Docs
Requirements
  • Bachelor's degree in life sciences or a relevant field, advanced degree preferred
  • 2-5 years working within the biotech/pharmaceutical industry, 1+ years of experience in regulatory affairs preferred
  • Prior experience with cell or gene therapies is highly preferred
  • Strong organizational skills and attention to detail
  • Ability to prioritize projects based on input from Manager
  • Strong verbal and written communication skills and interpersonal skills
  • Proficiency in Microsoft Word and Excel
  • Experience with Microsoft Power Point, MS Project, and Smartsheet preferred
Responsibilities
  • Support, prepare and/or coordinate routine regulatory submissions and other correspondence
  • Assist with creating and maintaining regulatory timelines and tracking deliverables
  • Interface with functional areas to obtain information required for regulatory submissions
  • Assist the team in executing regulatory strategy options
  • Monitor regulatory environment for changes to requirements
  • Maintain current knowledge and expertise of FDA/EMA regulations and ICH guidelines
  • Collaborate in preparing and maintaining SOPs and appropriate regulatory operating guidelines
  • Perform workflows and procedures regarding document tracking, indexing, and disseminating information
  • Serve as Regulatory support team member assisting cross-functional project teams

Adicet Bio, Inc. is a pioneering biotechnology company focused on the development of innovative gamma delta T cell therapies for cancer. This firm's work in advancing genetically modified T cells that selectively target tumors with chimeric antigen receptors and T cell receptor-like antibodies positions it as a leader in oncology treatment advancements. The dedication to enhancing tumor targeting and improving treatment persistence underscores a strong commitment to patient care and scientific excellence, making it a distinguished workplace for professionals passionate about making significant impacts in cancer treatment.

Company Stage

IPO

Total Funding

$243.6M

Headquarters

Redwood City, California

Founded

2014

Growth & Insights
Headcount

6 month growth

-4%

1 year growth

1%

2 year growth

44%